A Comparison of Hematological Profiles of Children With and Without Congenital Heart Defects Attending Two Selected

Chidimma S Nwike1, Ebele A Aronu2,3, Uchenna Ekwochi1

  • 1ESUT Teaching Hospital, Parklane, Enugu, Enugu State, Nigeria.

PubMed

Insights

Children with cyanotic congenital heart disease (CCHD) show significantly altered haematological profiles, including higher haematocrit and D-dimer levels, compared to those with acyanotic congenital heart disease (ACHD) or no heart defects.

Area of Science:

  • Pediatric Hematology
  • Cardiology
  • Congenital Heart Disease

Background:

  • Congenital heart defects (CHD) are common birth abnormalities.
  • Hematological profiles can be affected by the severity and type of CHD.
  • Understanding these changes is crucial for patient management.

Purpose of the Study:

  • To compare the haematological profiles of children with and without congenital heart defects (CHD).
  • To investigate differences between acyanotic congenital heart disease (ACHD) and cyanotic congenital heart disease (CCHD).

Main Methods:

  • A comparative, cross-sectional study design.
  • Inclusion of 90 children: 30 with ACHD, 30 with CCHD, and 30 controls without CHD.
  • Analysis of haematological parameters including haematocrit, PT, INR, TT, protein C, and D-dimer.

Main Results:

  • Children with CCHD exhibited significantly higher mean/median levels of haematocrit, PT, INR, TT, protein C, and D-dimer compared to ACHD patients.
  • ACHD patients also showed elevated levels compared to children without CHD.
  • Haematocrit and oxygen saturation were identified as key factors linked to abnormal haematological profiles.

Conclusions:

  • Cyanotic congenital heart disease is associated with distinct and significantly altered haematological profiles.
  • Hematological parameters differ based on the presence and type of congenital heart defect.
  • Further research into these haematological changes may improve clinical outcomes for pediatric CHD patients.
Abstract

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
61
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K